Furthermore, miR-133b transfection could modulate invasion, apoptosis and sensitivity to EGFR-TKI through the EGFR signaling pathways, specifically in EGFR-addicted NSCLC cells [178]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.